Trending...
- Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Fire Outside City of Tacoma Facility on Martin Luther King Jr. Way Temporarily Disrupts PEG Channels
Expert declares mental health and psychiatry are in a tailspin. CCHR warns of psychiatric treatment risks, rising drug deaths, and poor psychiatric hospital outcomes requiring close scrutiny.
LOS ANGELES - Washingtoner -- Citizens Commission on Human Rights International, a leading mental health industry watchdog, is calling for a federal audit of the $280 billion spent annually on mental health services, citing decades of failed outcomes and lack of meaningful improvements. Additionally, as CCHR has been exposing since the 1990s, millions of dollars have been wasted on National Institute of Mental Health (NIMH)-funded behavioral and psychiatric research that has included studying whiptail lizards, insects, electric fish and $3.1 million spent on the "vocal learning" of birds. Despite this massive investment, mental health in the U.S. continues to decline. CCHR warns that billions are being squandered on treatment-caused harm, overlooked polypharmacy risks, and rising deaths linked to psychotropic drugs.
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on Washingtoner
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on Washingtoner
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on Washingtoner
- Outreaching.io Appoints Rameez Ghayas Usmani as CEO, Recognized as Best HARO Link Building Expert in the United States
- Winzele: A Trusted Isolation Transformer Manufacturer
- Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
- ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
- UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on Washingtoner
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
- Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
- Spokane: Firework Thrown From a Vehicle Causes Severe Injuries to Another
- Spokane: Coffee With Council District 2 Council Members
- 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
Source: Citizens Commission on Human Rights
Filed Under: Government
0 Comments
Latest on Washingtoner
- $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
- 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
- uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
- Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
- Seattle Walk In Tubs Announces Service Area Expansion to Greater Seattle Region
- Seattle Bathroom Remodeling Announces Service Area Expansion to Greater Seattle Region
- Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
- Curated Domain Name Marketplace
- Spokane: Suspect in Custody After Committing Multiple Armed Robberies
- Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
- Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
- Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
- $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
- Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
- TradingHabits.com Launches to Support Day Trader Well-being
- $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
- Fire Outside City of Tacoma Facility on Martin Luther King Jr. Way Temporarily Disrupts PEG Channels
- $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
